Onyx Pharmaceuticals

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Onyx Pharmaceuticals ( ONXX) is a biopharmaceutical company engaged in developing therapies that target the molecular mechanisms that cause cancer.

Yesterday's Volume: 4,073,900

Average Volume: 1,278,280

Volume % Change: 211%

This stock added yesterday to its large gains from Monday of 14% as shares continue to attract buyers off optimism the company may be sold. A Bloomberg article mentioned that two people with knowledge of the matter said that the company is exploring options including a possible sale.

From a technical standpoint , this stock is running into some big overhead resistance at $45.90 to $46.07, where the sellers are overwhelming the buyers.

Despite the strong moves in this stock the last two trading sessions, I would not get interested from the long side until it can manage to take those resistance levels out with volume. This feels more like a case of sell-the-rumor than buy-the-rumor since the stock ran right into resistance.

I would only change my mind if ONXX can manage to sustain a high-volume move and close above $46.07 in the near future.

If you liked this article you might like

3 Industries and 3 Stocks Riding a 2012 M&A Boom

Idenix Falls Casualty to Gilead Hep C Hoopla

Gilead Wows With New Hep C Data, Boxing Out Poor 2012 Guidance

BioLineRx: Tuesday's Hot Hep C Drug Stock

Idenix Pharma Buyout Likely: Survey